Northlane Capital Partners: Buy Box & Recent Acquisitions

At a glance

Latest fund	Northlane Capital Partners Fund III, $750M (Oct 2025) S5
EBITDA range	$5M to $30M S2
Check size	$25M to $150M S2
Deal types	Platform, Add-on S2
Geography	North America S2
Sectors	Healthcare Services, Insurance Brokerage, Software & SaaS, Education, Accounting & Professional Services

What Northlane Capital Partners buys

Northlane Capital Partners is a Bethesda, Maryland private equity firm that invests in niche healthcare and business services companies in North America. Its published range for a new platform is $5 million to $30 million of EBITDA, or $50 million to $350 million of enterprise value, with $25 million to $150 million of equity per deal. It buys mainly from founders and smaller institutional owners, and it favors outsourced services with recurring revenue, steady demand and strong cash flow. Areas it names include lab services, behavioral health, healthcare IT, pharma services, insurance agencies, legal services, training and certification, and software and tech-enabled services.

Northlane grows each company through acquisitions and says it has completed more than 80 add-ons. It sets no minimum size for an add-on. It closed Fund III at $750 million in October 2025. A company under $5 million of EBITDA is most likely to meet Northlane as an add-on to a current platform such as Choice Financial Group, Stellar Public Adjusting or USDTL, each of which lists the add-ons it wants on the firm's portfolio page.

Recent deals

Announced in the 24 months before October 28, 2026.

Date	Company	Type	Sector	Source
Mar 2026	File & ServeXpressCourt eFiling and case management software provider, bought from Strait Lane Capital Partners	Platform	Software & SaaS	Source
Oct 2025	Northlane Capital Partners Fund IIIThird fund reached an oversubscribed final close at $750 million	Fund close		Source
Jul 2025	Empower Community CareSale of the behavioral health provider	Exit	Healthcare Services	Source
Jul 2025	The Difference CardSale of the employer healthcare cost containment provider	Exit		Source
Jan 2025	Plus Delta PartnersFundraising training and tools for colleges, health systems and other nonprofits	Platform	Education	Source
Jan 2025	United States Drug Testing LaboratoriesForensic toxicology lab founded in 1990 that tests for alcohol and drug use	Platform	Healthcare Services	Source
Nov 2024	IDEA PharmaAdded to SAI MedPartners, a consultancy serving drug and device makers	Add-on	Accounting & Professional Services	Source

Portfolio by sector

From the firm's portfolio page S3.

Business Services

Choice Financial Group
File & ServeXpress
Infobase
Plus Delta Partners
Stellar Public Adjusting

Healthcare

PAR Excellence Systems
SAI MedPartners
United States Drug Testing Laboratories

Other

Potpourri

Past investments: Empower Community Care, The Difference Card, VMG Health, Firma Clinical Research, MultiTech Systems, Affordable Care

Greymont’s take

How Northlane Capital Partners fits a seller

Northlane suits founders of healthcare or business services companies with at least $5 million of EBITDA who want help buying competitors. The firm says it often acts as the corporate development team for its companies, and its portfolio CEOs describe add-ons closing soon after Northlane arrived. It has bought from founders who leave at closing, founders who stay on as CEO, and owners in between, so a seller has room to shape their own role.

Smaller owners of insurance agencies, public adjusting firms, toxicology labs, court technology or fundraising training businesses should read the add-on criteria on each portfolio page, since Northlane sets no minimum size for add-ons. Owners should also ask how long Northlane expects to hold the platform and what happens to rolled equity at the next sale. Its 2024 sale of PAR Excellence Systems left Northlane and management as continuing investors.

Questions owners ask

What size company does Northlane Capital Partners buy?

For a new platform it targets $5 million to $30 million of EBITDA and $50 million to $350 million of enterprise value, investing $25 million to $150 million of equity. It sets no minimum size for add-ons.

Which industries does Northlane focus on?

Only healthcare and business services. Its strategy page names areas such as behavioral health, dental services, lab services, healthcare IT, pharma services, insurance services, legal services, training and certification, and asset-light logistics.

Can the founder stay on after Northlane buys the company?

Yes. The firm says it has bought from founders who fully exit at closing, founders who stay on as CEO, and everything in between.

Does Northlane buy smaller companies as add-ons?

Yes. It says it has completed more than 80 add-on deals and has no minimum size for them. Each portfolio company page lists the kinds of add-ons it wants, such as insurance agencies for Choice Financial Group and toxicology labs for USDTL.

Sources

S1Northlane Capital Partners home page Accessed October 28, 2026
S2Northlane Capital Partners: Investment Strategy Accessed October 28, 2026
S3Northlane Capital Partners: Portfolio Accessed October 28, 2026
S4Northlane Capital Partners: Business Owners Accessed October 28, 2026
S5Northlane Capital Partners: Latest News Accessed October 28, 2026
S6File & ServeXpress Secures Strategic Growth Investment through Acquisition by Northlane Capital Partners (March 3, 2026) Accessed October 28, 2026
S7Northlane Capital Partners Announces Final Close of Oversubscribed Fund III at $750 Million (Business Wire, linked from the firm's newsroom; not opened) Accessed October 28, 2026

Compiled by Greymont Advisors from public sources, including the firm’s own website and press releases. Greymont is not affiliated with Northlane Capital Partners. Figures are as reported on the dates shown and may have changed. Request a correction